JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2005;58:820-825; doi:10.1136/jcp.2004.023143
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luzar, B
Right arrow Articles by Ferlan-Marolt, V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luzar, B
Right arrow Articles by Ferlan-Marolt, V
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Gallbladder Cancer

ORIGINAL ARTICLE

Expression of human telomerase catalytic protein in gallbladder carcinogenesis

B Luzar1, M Poljak2, A Cör3, U Klopcic4, V Ferlan-Marolt1

1 Institute of Pathology, Medical Faculty, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia
2 Institute of Microbiology and Immunology, Medical Faculty, University of Ljubljana, Zaloska 4
3 Institute of Histology and Embryology, Medical Faculty, University of Ljubljana, Korytkova 2
4 Department of Cytopathology, Institute of Oncology, Zaloska 4, 1000 Ljubljana, Slovenia

Correspondence to:
Assistant Professor B Luzar
Institute of Pathology, Medical Faculty, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia; bostjan.luzar{at}mf.uni-lj.si Background: Telomerase catalytic subunit (hTERT) gene re-expression is a rate limiting step for the activity of telomerase, a key enzyme implicated in cellular immortalisation and transformation.

Aims: To determine the potential role of hTERT protein in gallbladder carcinogenesis.

Material/Methods: hTERT protein was analysed by means of immunohistochemistry in 89 gallbladder tissue samples: 16 normal epithelia, 14 reactive hyperplasias, 15 low grade dysplasias, 16 high grade dysplasias, and 28 adenocarcinomas. At least 200 nuclei were assessed for each slide and the mean number of positive signals for each nucleus was expressed as the hTERT index.

Results: The mean hTERT index increased progressively with the degree of gallbladder epithelial abnormalities: from 0.03 in normal epithelia, 0.04 in hyperplastic epithelia, 0.25 in low grade dysplasia, 0.82 in high grade dysplasia, to 0.93 in adenocarcinoma. Statistical analysis revealed that three different groups of gallbladder epithelial changes can be distinguished according to the number of hTERT signals for each nucleus: (1) normal and regenerative gallbladder epithelium, (2) low grade dysplasia, and (3) high grade dysplasia and adenocarcinoma (p < 0.001).

Conclusions: The occasional presence of hTERT protein in normal and regenerative gallbladder mucosa reflects their regenerative capacity. Nevertheless, significantly higher hTERT indices in low and high grade dysplastic epithelia and in gallbladder adenocarcinomas are probably a consequence of hTERT re-expression—an early event in the multistep process of gallbladder carcinogenesis.


Abbreviations: hTERT, human telomerase reverse transcriptase; TRAP, telomeric repeat amplification protocol

Keywords: gallbladder carcinogenesis; dysplasia; adenocarcinoma; telomerase catalytic protein (hTERT); immunohistochemistry




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
Y.-L. Wu, C. Dudognon, E. Nguyen, J. Hillion, F. Pendino, I. Tarkanyi, J. Aradi, M. Lanotte, J.-H. Tong, G.-Q. Chen, et al.
Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths
J. Cell Sci., July 1, 2006; 119(13): 2797 - 2806.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.